Smith & Nephew plc (NYSE: SNN) stock fell -3.08% on Friday to $24.84 against a previous-day closing price of $25.63. With 4.3 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.76 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $25.53 whereas the lowest price it dropped to was $24.80. The 52-week range on SNN shows that it touched its highest point at $40.29 and its lowest point at $25.34 during that stretch. It currently has a 1-year price target of $35.80. With its current market cap of 10.87 billion, SNN has annualized dividend of $1.04 while the current yield stands at 4.18%. Beta for the stock currently stands at 0.62.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SNN was down-trending over the past week, with a drop of -13.09%, but this was down by -11.19% over a month. Three-month performance dropped to -22.69% while six-month performance fell -26.64%. The stock lost -37.35% in the past year, while it has lost -28.25% so far this year. EPS is expected to grow by 4.60% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -7.40%.
Float and Shares Shorts:
At present, 438.12 million SNN shares are outstanding with a float of 435.09 million shares on hand for trading. On Jul 14, 2022, short shares totaled 0.8 million, which was 0.18% higher than short shares on Jun 14, 2022. In addition to Ms. Anne-Francoise Nesmes as the firm’s CFO & Exec. Director, Dr. Deepak S. Nath Ph.D. serves as its CEO & Director.
Through their ownership of 8.97% of SNN’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 5.69% of SNN, in contrast to 2.84% held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in SNN with 2.35% of the stake, Nuance Investments LLC holds 10,256,123 shares worth 10,256,123. A second-largest stockholder of SNN, Fiduciary Management, Inc., holds 7,622,581 shares, controlling over 1.75% of the firm’s shares. Millennium Management LLC is the third largest shareholder in SNN, holding 1,330,243 shares or 0.31% stake. With a 1.19% stake in SNN, the Nuance Mid Cap Value Fund is the largest stakeholder. A total of 5,204,945 shares are owned by the mutual fund manager. The FMI Large Cap Fund, which owns about 0.50% of SNN stock, is the second-largest Mutual Fund holder. It holds 2,200,000 shares valued at 61.42 million. Nuance Concentrated Value Fund holds 0.21% of the stake in SNN, owning 915,333 shares worth 25.56 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. Over the past year, revenue came in at $5.21B while operating income stood at $596.00M. EBITDA for the full year was $1.31B.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SNN since 13 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 6 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With SNN analysts setting a high price target of $43.67 and a low target of $28.44, the average target price over the next 12 months is $35.12. Based on these targets, SNN could surge 75.81% to reach the target high and rise by 14.49% to reach the target low. Reaching the average price target will result in a growth of 41.38% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. SNN will report FY 2022 earnings on 02/09/2023. Analysts have provided yearly estimates in a range of $1.74 being high and $1.56 being low. For SNN, this leads to a yearly average estimate of $1.66. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate.
Summary of Insider Activity:
Insiders traded SNN stock several times over the past three months with 3 Buys and 0 Sells. In these transactions, 81,549 shares were bought while 0 shares were sold. The number of buy transactions has increased to 9 while that of sell transactions has risen to 3 over the past year. The total number of shares bought during that period was 99,628 while 10,996 shares were sold.